InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by HUME DANIEL, Director. Director active across 1 companies, notably TG Therapeutics, INC.. In total, 2 reports have been published. The latest transaction was filed on 18 June 2021 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
020,000 shares0
COMMON STOCK
SEC:0001104659-21-084259·
020,000 shares0
COMMON STOCK
SEC:0001104659-21-084259:0·
2 of 2 declarations
About HUME DANIEL
Daniel Hume is a Director at TG THERAPEUTICS, INC. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the pharmaceutical sector and understanding of market challenges allow him to provide valuable insights during board discussions.
